An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis

NCT03656068 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Non-alcoholic Steatohepatitis
Fatty Liver
Fibrosis, Liver
Compensated Cirrhosis

Interventions

DRUG: Nitazoxanide 500mg BID

Sponsor

Pinnacle Clinical Research, PLLC